Cancer treatment and survivorship statistics, 2016
By K. Miller, R. Siegel, C. Lin, A. Mariotto, J. Kramer, Julia H. Rowland, K. Stein, Rick Alteri, A. Jemal. Ca, 2016
5,540 citations recorded by the source corpus.
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For the public health community to better serve these survivors, the American Cancer Society and the National Cancer Institute collaborate to estimate the number of current and future cancer survivors using data from the Surveillance, Epidemiology, and End Results cancer registries. In addition, current treatment patterns for the most prevalent cancer types are presented based on information in the National Cancer Data Base and treatment‐related side effects are briefly described. More than 15.5 million Americans with a history of cancer were alive on January 1, 2016, and this number is projected to reach more than 20 million by January 1, 2026. The 3 most prevalent cancers are prostate (3,306,760), colon and rectum (724,690), and melanoma (614,460) among males and breast (3,560,570), uterine corpus (757,190), and colon and rectum (727,350) among females. More than one‐half (56%) of survivors were diagnosed within the past 10 years, and almost one‐half (47%) are aged 70 years or older. People with a history of cancer have unique medical and psychosocial needs that require proactive assessment and management by primary care providers. Although there are a growing number of tools that can assist patients, caregivers, and clinicians in navigating the various phases of cancer survivorship, further evidence‐based resources are needed to optimize care. CA Cancer J Clin 2016;66:271‐289. © 2016 American Cancer Society
Subfields: Epidemiology, Public Health, Environmental and Occupational Health, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/5cd118acd07265bc6012ae7c25e7ae0af3f7e6a0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Public Health, Environmental and Occupational Health
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020, background): “There were an estimated 15 million cancer survivors in the United States in 2016 with over 20 million estimated by 2026.(176) There is a major unmet need to address important CV comorbidities that may coincide or result from anticancer therapy in survivors and effectively address appropriate follow-”
- Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer (2018, neutral): “In the United States, an additional 224,390 new lung cancer cases were diagnosed in 2016, and accounted for about 27% of all cancer deaths [1].”
- Breast cancer statistics, 2017, racial disparity in mortality by state (2017, background): “5 million US women with a history of breast cancer were alive on January 1, 2016.(32) Figure 9 present trends in 5-year relative survival for breast cancer by race and stage at diagnosis from 1975 through 1977 to 2007 through 2013.”
- Colorectal cancer statistics, 2017 (2017, background): “This progress reflects important improvements in treatment, including adjuvant therapy for resectable stage III colon cancer,80-82 preoperative chemoradiation for locally advanced rectal cancer,83,84 and cancerdirected surgery for advanced CRC.85 Advances in the treatment of liver metastases,86,87 n”
- Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes (2019, background): “Pancreatic ductal adenocarcinoma (PDAC) is a disease of near uniform mortality (Hidalgo, 2010; Kamisawa et al., 2016; Miller et al., 2016).”
- Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients (2019, background): “INTRODUCTION Chemotherapy is still considered the backbone of anticancer therapy and has improved the life expectancy of countless patients (1, 2).”
- Exercise Guidelines for Cancer Survivors: Consensus statement from International Multidisciplinary Roundtable (2019, background): “Cancer is also a disease strongly linked with aging, and almost half of survivors are older than 70 yr (5).”